Latest Laboratory techniques Stories

CARLSBAD, California, November 19, 2012 /PRNewswire/ -- Flagship qPCR instrument offers reliability, accuracy, ease of use and flexibility for IVD and lab-developed diagnostic tests Life Technologies Corporation [http://www.lifetech.com ] (NASDAQ:LIFE [http://finance.yahoo.com/q?s=life ]) today announced the launch of its Applied Biosystems QuantStudio(TM) Dx Real-Time PCR Instrument designed to meet the specific needs of clinical diagnostic...

CARLSBAD, Calif., Nov. 15, 2012 /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in soil, stool and microbial nucleic acid purification, announces the launch of the PowerFecal(TM) DNA Isolation Kit. The kit is optimized for isolation of high quality DNA from stool, gut material and biosolids, and provides high quality DNA for use in characterizing the human microbiome. (Photo: http://photos.prnewswire.com/prnh/20121115/LA13824) The PowerFecal(TM) DNA Isolation Kit is the...

PORT MATILDA, Pa., Nov. 13, 2012 /PRNewswire/ -- QBC Diagnostics, a global manufacturer of hematology and infectious disease diagnostics equipment, announced today that the company's U.S. General Services Administration (GSA) Schedule 66 Contract for Scientific Equipment and Services is now publicly available online through the GSA Advantage!( ®) website. With GSA Advantage!( ® )Federal employees are able to research, compare, and purchase a complete range of products and services...

FREMONT, Calif., Nov. 9, 2012 /PRNewswire/ -- WaferGen Bio-systems, Inc. (OTCBB: WGBS) announced today that it obtained an exclusive license from Rutgers University for the patent covering a novel RNA Quality Control technology, which was developed at RUCDR Infinite Biologics under the leadership of Drs. Jay A. Tischfield and Andrew I. Brooks. The company intends to develop and commercialize products based on the patent's concept utilizing WaferGen's high throughput qPCR SmartChip...

CARLSBAD, Calif., Nov. 7, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announces the QuantStudio(TM) 3D Digital PCR System, a scalable, chip-based instrument that is democratizing this technology for a rapidly growing market. Featuring a simple workflow with minimal hands-on time, the benchtop platform is disruptively priced at $30,000 -- enabling access to a broader community. The system is currently with early access customers and commercial shipments...

FARMINGTON, Conn., Nov. 5, 2012 /PRNewswire-iReach/ -- Techniques such as PCR, DNA microarray, DNA sequencing, mass spectrometry and flow cytometry have driven discoveries that have changed our understanding of the world. By 2015, the combined global markets for these five areas are expected to exceed $50 billion. (Photo: http://photos.prnewswire.com/prnh/20121105/CG06410) From now until December 31, Global Information Inc (GII), in exclusive partnership with our premium research...

CARLSBAD, Calif., Nov. 5, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of Advanced Microscopy Group or AMG, a privately held developer of imaging systems for research microscopy incorporated as Westover Scientific, Inc. The manufacturer of the FLoid® Cell Imaging Station currently sold by Life, AMG enables Life to expand its product line of cell imaging instrumentation, while leveraging its Molecular Probes® portfolio of...

BOULDER, Colo., AMSTERDAM and VIENNA, Nov. 1, 2012 /PRNewswire/ -- BiOptix today announced that it would be highlighting the new BiOptix 404pi, the first commercially available SPR instrument to incorporate phase-based common path interferometry technology, at the Label Free Technologies Show in Amsterdam from November 1 - 3 as well as at the PEGS Europe Summit on November 6 - 8. "At the Label Free and PEGS Europe meetings, BiOptix will unveil new application data that...

HAYWARD, Calif., Nov. 1, 2012 /PRNewswire/ -- Advanced Cell Diagnostics, Inc., a world leader in the field of in situ nucleic acid detection for life science research and clinical diagnostics, announced today that it has completed its $12 million Series B equity financing. New Leaf Venture Partners, a leader in healthcare technology venture investing, and the existing investor Morningside Ventures participated in the round. Proceeds from the financing will be used to support the...

ANN ARBOR, Mich., Nov. 1, 2012 /PRNewswire/ -- Rubicon Genomics, Inc. today announced that it has partnered with Diagenode SA to integrate Rubicon's ThruPLEX(TM) technology into Diagenode's epigenetics platforms to increase the efficiency and quality of DNA sample preparation for chromatin immunoprecipitation (ChIP) applications. The new agreement allows Diagenode to incorporate the Rubicon ThruPLEX-FD technology into its new MicroPLEX Library Preparation Kit for ChIP-seq studies...